China Universal Asset Management Company’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Buy |
11,885
+30
| +0.3% | +$693 | 0.03% | 286 |
|
|
2025
Q1 | $320K | Buy |
11,855
+727
| +7% | +$19.6K | 0.03% | 281 |
|
|
2024
Q4 | $596K | Buy |
11,128
+1,095
| +11% | +$58.6K | 0.06% | 231 |
|
|
2024
Q3 | $456K | Buy |
10,033
+3,943
| +65% | +$179K | 0.05% | 233 |
|
|
2024
Q2 | $255K | Sell |
6,090
-3,653
| -37% | -$153K | 0.04% | 210 |
|
|
2024
Q1 | $367K | Buy |
9,743
+4,400
| +82% | +$166K | 0.05% | 212 |
|
|
2023
Q4 | $57.3K | Buy |
+5,343
| New | +$57.3K | 0.01% | 359 |
|
|
2022
Q4 | – | Sell |
-390
| Closed | -$5K | – | 423 |
|
|
2022
Q3 | $5K | Buy |
+390
| New | +$5K | ﹤0.01% | 273 |
|